| Product Code: ETC7549014 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Non-Hodgkin Lymphoma Diagnostics Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 India Non-Hodgkin Lymphoma Diagnostics Market - Industry Life Cycle |
3.4 India Non-Hodgkin Lymphoma Diagnostics Market - Porter's Five Forces |
3.5 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.6 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Cancer Stage, 2021 & 2031F |
3.7 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Tumor Type, 2021 & 2031F |
3.8 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.9 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.10 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Non-Hodgkin Lymphoma Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of non-Hodgkin lymphoma cases in India |
4.2.2 Growing awareness and adoption of early screening and diagnosis |
4.2.3 Technological advancements in diagnostic tools and techniques |
4.3 Market Restraints |
4.3.1 Limited access to advanced diagnostic facilities in rural areas |
4.3.2 High cost associated with diagnostic tests and treatments |
4.3.3 Lack of skilled healthcare professionals specializing in non-Hodgkin lymphoma diagnostics |
5 India Non-Hodgkin Lymphoma Diagnostics Market Trends |
6 India Non-Hodgkin Lymphoma Diagnostics Market, By Types |
6.1 India Non-Hodgkin Lymphoma Diagnostics Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Test Type, 2021- 2031F |
6.1.3 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Imaging, 2021- 2031F |
6.1.4 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.1.5 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F |
6.1.6 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Biomarker Test, 2021- 2031F |
6.1.7 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Genetic Test, 2021- 2031F |
6.1.8 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Cytogenetics, 2021- 2031F |
6.1.9 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Non-Hodgkin Lymphoma Diagnostics Market, By Cancer Stage |
6.2.1 Overview and Analysis |
6.2.2 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Stage 0, 2021- 2031F |
6.2.3 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Stage I, 2021- 2031F |
6.2.4 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Stage Ii, 2021- 2031F |
6.2.5 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Stage Iii, 2021- 2031F |
6.2.6 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Stage Iv, 2021- 2031F |
6.3 India Non-Hodgkin Lymphoma Diagnostics Market, By Tumor Type |
6.3.1 Overview and Analysis |
6.3.2 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Aggressive Lymphomas, 2021- 2031F |
6.3.3 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Indolent Lymphomas, 2021- 2031F |
6.4 India Non-Hodgkin Lymphoma Diagnostics Market, By Product |
6.4.1 Overview and Analysis |
6.4.2 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Instrument Based Products, 2021- 2031F |
6.4.3 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Platform Based Products, 2021- 2031F |
6.4.4 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Kits And Reagents, 2021- 2031F |
6.4.5 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Other Consumables, 2021- 2031F |
6.5 India Non-Hodgkin Lymphoma Diagnostics Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Fluorescent In Situ Hybridization, 2021- 2031F |
6.5.3 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Next Generation Sequencing, 2021- 2031F |
6.5.4 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Fluorimmunoassay, 2021- 2031F |
6.5.5 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Comparative Genomic Hybridization, 2021- 2031F |
6.5.6 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Immunohistochemical, 2021- 2031F |
6.5.7 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.6 India Non-Hodgkin Lymphoma Diagnostics Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Screening, 2021- 2031F |
6.6.3 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Diagnostic And Predictive, 2021- 2031F |
6.6.4 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Prognostic, 2021- 2031F |
6.6.5 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Research, 2021- 2031F |
6.7 India Non-Hodgkin Lymphoma Diagnostics Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.7.3 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.7.4 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Academic Institutes, 2021- 2031F |
6.7.5 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Academic Institutes, 2021- 2031F |
6.7.6 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.7.7 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.8 India Non-Hodgkin Lymphoma Diagnostics Market, By Distribution Channel |
6.8.1 Overview and Analysis |
6.8.2 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.8.3 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By Retail Sales, 2021- 2031F |
6.8.4 India Non-Hodgkin Lymphoma Diagnostics Market Revenues & Volume, By , 2021- 2031F |
7 India Non-Hodgkin Lymphoma Diagnostics Market Import-Export Trade Statistics |
7.1 India Non-Hodgkin Lymphoma Diagnostics Market Export to Major Countries |
7.2 India Non-Hodgkin Lymphoma Diagnostics Market Imports from Major Countries |
8 India Non-Hodgkin Lymphoma Diagnostics Market Key Performance Indicators |
8.1 Average time taken from diagnosis to treatment initiation |
8.2 Rate of adoption of advanced diagnostic technologies |
8.3 Number of healthcare facilities offering specialized non-Hodgkin lymphoma diagnostics services |
9 India Non-Hodgkin Lymphoma Diagnostics Market - Opportunity Assessment |
9.1 India Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.2 India Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Cancer Stage, 2021 & 2031F |
9.3 India Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Tumor Type, 2021 & 2031F |
9.4 India Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.5 India Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.6 India Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 India Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
9.7 India Non-Hodgkin Lymphoma Diagnostics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Non-Hodgkin Lymphoma Diagnostics Market - Competitive Landscape |
10.1 India Non-Hodgkin Lymphoma Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 India Non-Hodgkin Lymphoma Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here